Advertisement
Screener

DiaMedica Therapeutics Inc. (DMAC) Other

DiaMedica Therapeutics Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-30: Form 10-K; Item Stock registered under Section 12(b); As filed Voting Common Shares, no par value per share · DMAC · NASDAQ.
  • 2025-03-17: Form 10-K; Item Stock registered under Section 12(b); As filed Voting Common Shares, no par value per share · DMAC · NASDAQ.
  • 2024-03-19: Form 10-K; Item Stock registered under Section 12(b); As filed Voting Common Shares, no par value per share · DMAC · NASDAQ.
  • 2023-11-13: Form 10-Q; Item Emerging growth company; As filed Yes.
FiledFormItemAs filed
2026-03-3010-KStock registered under Section 12(b)Voting Common Shares, no par value per share · DMAC · NASDAQ
2025-03-1710-KStock registered under Section 12(b)Voting Common Shares, no par value per share · DMAC · NASDAQ
2024-03-1910-KStock registered under Section 12(b)Voting Common Shares, no par value per share · DMAC · NASDAQ
2023-11-1310-QEmerging growth companyYes
2023-08-1410-QEmerging growth companyYes
2023-05-1510-QEmerging growth companyYes
2023-03-2810-KStock registered under Section 12(b)Voting Common Shares, no par value per share · DMAC · NASDAQ
2023-03-2810-KEmerging growth companyYes
2022-11-0910-QEmerging growth companyYes
2022-08-1110-QEmerging growth companyYes
2022-05-0410-QEmerging growth companyYes
2022-03-1410-KStock registered under Section 12(b)Voting Common Shares, no par value per share · DMAC · NASDAQ
2022-03-1410-KEmerging growth companyYes
2022-03-1410-KCurrent in its reportingNo
2021-11-1010-QEmerging growth companyYes
2021-08-1110-QEmerging growth companyYes
2021-05-0510-QStock registered under Section 12(b)Voting common shares, no par value per share · dmac
2021-05-0510-QEmerging growth companyYes
2021-03-1010-KStock registered under Section 12(b)Voting common shares, no par value per share · dmac
2021-03-1010-KEmerging growth companyYes
2021-03-1010-KCurrent in its reportingNo
2020-11-0410-QStock registered under Section 12(b)Voting common shares, no par value per share · dmac
2020-11-0410-QEmerging growth companyYes
2020-11-0410-QCurrent in its reportingNo
2020-08-1110-QStock registered under Section 12(b)Voting common shares, no par value per share · dmac
2020-08-1110-QEmerging growth companyYes
2020-08-1110-QCurrent in its reportingNo
2020-05-1310-QStock registered under Section 12(b)Voting common shares, no par value per share · dmac
2020-05-1310-QEmerging growth companyYes
2020-05-1310-QCurrent in its reportingNo
2020-03-2310-KStock registered under Section 12(b)Voting Common Shares, no par value per share · dmac
2020-03-2310-KEmerging growth companyYes
2020-03-2310-KCurrent in its reportingNo
2019-11-1310-QStock registered under Section 12(b)Voting common shares, no par value per share · dmac
2019-11-1310-QEmerging growth companyYes
2019-08-1310-QStock registered under Section 12(b)Common Stock · dmac
2019-08-1310-QEmerging growth companyYes
2019-05-1310-QEmerging growth companyYes
2019-03-1910-KEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68